Analysen von Michael Leuchten
| 26.03.21 | AstraZeneca buy | UBS AG | |
| 23.03.21 | AstraZeneca buy | UBS AG | |
| 11.03.21 | Bayer buy | UBS AG | |
| 02.03.21 | AstraZeneca buy | UBS AG | |
| 26.02.21 | Bayer buy | UBS AG | |
| 25.02.21 | Bayer buy | UBS AG | |
| 25.02.21 | AstraZeneca buy | UBS AG | |
| 22.02.21 | Bayer buy | UBS AG | |
|
Werbung
|
|||
| 04.02.21 | Bayer buy | UBS AG | |
| 12.01.21 | Roche buy | UBS AG | |
| 10.11.20 | Roche buy | UBS AG | |
| 03.11.20 | Bayer buy | UBS AG | |
| 29.10.20 | Roche buy | UBS AG | |
| 26.10.20 | Bayer buy | UBS AG | |
| 16.10.20 | Roche buy | UBS AG | |
| 15.10.20 | Roche buy | UBS AG | |
| 14.10.20 | Bayer buy | UBS AG | |
| 05.10.20 | Bayer buy | UBS AG | |
| 01.10.20 | Bayer buy | UBS AG | |
| 30.09.20 | Roche buy | UBS AG | |
| 18.09.20 | Roche buy | UBS AG | |
| 02.09.20 | Roche buy | UBS AG | |
| 11.08.20 | Roche buy | UBS AG | |
| 04.08.20 | Bayer buy | UBS AG | |
| 30.07.20 | Roche buy | UBS AG | |
| 27.07.20 | Roche buy | UBS AG | |
| 23.07.20 | Roche buy | UBS AG | |
| 22.07.20 | Bayer buy | UBS AG | |
| 10.07.20 | Bayer buy | UBS AG | |
| 09.07.20 | Bayer buy | UBS AG | |
| 08.07.20 | Bayer buy | UBS AG | |
| 01.07.20 | Bayer buy | UBS AG | |
| 25.06.20 | Bayer buy | UBS AG | |
| 23.06.20 | Bayer buy | UBS AG | |
| 15.06.20 | Bayer buy | UBS AG | |
| 10.06.20 | Bayer buy | UBS AG | |
| 05.06.20 | Bayer buy | UBS AG | |
| 14.05.20 | Roche buy | UBS AG | |
| 13.05.20 | Roche buy | UBS AG | |
| 06.05.20 | Novo Nordisk buy | UBS AG | |
| 28.04.20 | Roche buy | UBS AG | |
| 27.04.20 | Bayer buy | UBS AG | |
| 23.04.20 | Roche buy | UBS AG | |
| 17.04.20 | Novo Nordisk buy | UBS AG | |
| 15.04.20 | Novo Nordisk buy | UBS AG | |
| 24.03.20 | Roche buy | UBS AG | |
| 23.03.20 | Novo Nordisk buy | UBS AG | |
| 03.03.20 | Bayer buy | UBS AG | |
| 27.02.20 | Bayer buy | UBS AG | |
| 07.02.20 | Roche buy | UBS AG | |